Recently, the Food and Drug Administration (FDA) has published regulatory recommendations on guaranteeing safety, and efficiency of [url=https://masmaz.com/2025/04/06/hello-world/]https://masmaz.com/2025/04/06/hello-world/[/url] (59). in such recommendations announce that methods therapy using stem cells that have undergone minimal manipulation and are designed for homogeneous applications do not take prior approval on the market to begin operation and must comply only regulatory recommendations for prevention of disease transmission.